Clinical trials
Enrolling by invitation Observational Neuromuscular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ottawa Hospital Research Institute | 2 |
| Istanbul University | 1 |
| LMU Klinikum | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromuscular Diseases | 4 |
| Amyotrophic Lateral Sclerosis | 1 |
| Friedreich Ataxia | 1 |
| Glycogen Storage Disease Type II | 1 |
| Guillain-Barre Syndrome | 1 |
| Hereditary Sensory and Motor Neuropathy | 1 |
| Lambert-Eaton Myasthenic Syndrome | 1 |
| Muscular Atrophy, Spinal | 1 |
| Muscular Dystrophy, Duchenne | 1 |
| Muscular Dystrophy, Facioscapulohumeral | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.